Zuellig Pharma has been appointed as the exclusive distribution partner for STADA Philippines.
The partnership, effective from 1 January 2024, will see Zuellig Pharma distribute STADA’s range of pharmaceuticals across the Philippines.
Leveraging its established presence in the local market, Zuellig Pharma will manage the distribution of over 70 products, including over-the-counter (OTC) brands, consumer healthcare products, and prescription medicines.
This includes notable brands such as FERN-C vitamin C, Oilatum skincare, and ophthalmic products like Hyabak eye drops. The partnership will also introduce essential generic medicines in therapeutic areas such as antibiotics and cardiovascular care.
The collaboration is expected to enhance access to high-quality healthcare products across pharmacies, supermarkets, hospitals, and clinics in the Philippines. It also supports STADA’s strategic growth plans in Southeast Asia, further strengthening its position in the region.
STADA, with over 125 years of history, is one of Europe’s leading suppliers of medicines and healthcare products, with a strong presence in consumer healthcare and generic medicines. The company is expanding rapidly in emerging markets, including the Philippines, where it aims to solidify its position as a key player.
This partnership underscores the commitment of both companies to improve healthcare accessibility and provide high-quality medicines to communities across the Philippines.